NEWS

Our Latest News

ARCHIMED acquires Groupe Laboratoire Rivadis, a leading player in baby and elderly skincare products

Global private equity healthcare specialist ARCHIMED further expands its presence in the Consumer Health sector with the acquisition of Groupe Laboratoire Rivadis.

ARCHIMED acquires Groupe Laboratoire Rivadis, a leading player in baby and elderly skincare products

ARCHIMED invests in Corealis Pharma, a North American CDMO, through MED III

 May

 24, 

2022

ARCHIMED’s MED II fund earns a 6x return on EUROLyser, its first exit

 May

 9, 

2022

ARCHIMED sells health ingredients developer Fytexia to Associated British Foods

 February

 2, 

2022

ARCHIMED buys CARSO, a leader in purity testing for pharma and other industries

 December

 16, 

2021

ARCHIMED reaches agreement to sell Bomi Group to UPS

 December

 16, 

2021

ARCHIMED buys a majority stake in SUANFARMA a leading manufacturer and distributor of active pharmaceutical and nutraceutical ingredients

 November

 18, 

2021

1 … 4 5 6 7 8 … 16
368